Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Poznan
Clinical trial register · Poland

Clinical Trials in Poznan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 27 Krakow 21 Lodz 21 Poznan 20 Gdansk 20
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw27 Krakow21 Lodz21 Poznan20 Gdansk20
All 40 locations
Target enrolment
to

Trials with a site in Poznan

20 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
Novartis Pharmaceuticals
Phase 3
650
Krosno, Poznan, Gdansk
2026-04-16
Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals
Phase 3
240
Gdansk, Gliwice, Krakow, Poznan, Warsaw
2025-05-30
Recruiting
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
NCT06865651Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals
Phase 2
44
Poznan, Rzeszów, Warsaw
2025-05-22
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Lublin, Krakow, Bydgoszcz, Katowice, Lodz, Poznan, Skorzewo, Warsaw
2025-02-07
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Poznan
2024-10-24
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Poznan, Lodz
2024-09-04
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Lublin, Warsaw, Krakow, Katowice, Bydgoszcz, Poznan, Rzeszów
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Poznan, Krakow, Wroclaw, Bydgoszcz, Warsaw
2023-10-27
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Poznan, Bialystok, Krakow, Olsztyn, Warsaw, Wroclaw
2023-10-02
Active, closed
Novartis Pharmaceuticals
Phase 3
109
Poznan, Gliwice, Gdansk, Lodz
2023-10-02
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Bialystok, Lodz, Poznan, Warsaw
2022-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Poznan, Krakow, Wroclaw, Warsaw
2022-08-04
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Wroclaw, Bydgoszcz, Kielce, Lodz, Lublin, Piotrkow Trybunalski, Poznan, Rzeszów
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Gdansk, Lodz, Poznan, Warsaw
2021-10-05
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
Novartis Pharmaceuticals
Phase 4
1,000
Krakow, Wroclaw, Warsaw, Bialystok, Bydgoszcz, Poznan, Sochaczew, Torun
2020-12-22
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Gdansk, Poznan
2019-10-30
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
Novartis Pharmaceuticals
Phase 1/2
300
Gdansk, Krakow, Lodz, Poznan, Warsaw
2019-09-18
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Bydgoszcz, Gdansk, Glogow Wielkopolski, Katowice, Kielce, Lodz, Poznan, Rzeszów
2018-12-28
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Lodz, Lublin, Poznan, Wroclaw
2013-07-26
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/poznan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies with a site in Poznan that also match the filters currently applied.

How many clinical trials are recruiting in Poznan?

8 of the 20 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Poznan), 20 studies
PhaseStudiesRecruitingShare
Phase 313365%
Phase 1/23315%
Phase 22110%
Phase 1105%
Phase 4115%

Most active sponsors

Lead sponsors with the most studies (Poznan)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals208
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.